rndtbl posted this link on the IV Board - 

On Sat April 7 Mr Lu will sit as a panelist on the health care forum

Shawn Lu is currently Executive Director at Hepalink USA, responsible for over 10 M&A in North America and Europe. Mr. Lu has over 25 years of experience in IPO, financial restructuring, overseas listing, M&A, credit and investment management. He has a deep understanding in global capital market. Mr. Lu has designations of Canadian Investment Manager and China Certified Public Accountant.

With a 42% interest in RVX and right of first refusal on US territory for apabetalone, Mr Lu and Hepa are nicely positioned to jump this cash starved startup. Not hard to put the dots together on this one.

Will RVX be mentioned at the forum?

Chicagoest